Author Guidelines

Manuscripts intended for submission to the OneHealth Plus Journal can be prepared using the sample files. The sample title page, main text, and copyright release form files can be downloaded from the links below:

1. AUTHORSHIP RESPONSIBILITY

Authorship responsibility of the articles lies with the authors. The authors of the submitted manuscript are expected to have contributed to the work.

2. PUBLICATION CHARGES

OneHealth Plus Journal does not charge any submission, processing, and publication fee.

3. ETHICAL RESPONSIBILITY

3.1. For studies conducted on live humans/animals

All the submitted manuscripts must comply with the ethical standards for animal studies. Experimental studies on animals must state the approval of study protocol by the institutional/local animal care and use committee(s). The authors are required to submit the documented approval of studies.

3.2. For use of previously published materials:

The use of previously published text, table(s), or figure(s) is subjected to written permission from the copyright holder. The authors must indicate the used materials in the submitted manuscript. The editorial team may request the data and/or the specific codes used in the study.

3.3. Plagiarism policy

Manuscripts submitted to the OneHealth Plus Journal are evaluated for plagiarism and similarity through detection software packages (iThenticate and Turnitin).

The acceptable threshold of the similarity index is 25%, however, the editorial team may decide to return the manuscript based on the plagiarism or the extent of similarity from a single document.

Plagiarism detected in any published article will be immediately retracted along with the blacklisting of the author(s).

4. TYPES OF ARTICLES

OneHealth Plus Journal publishes original research articles, case reports, review articles, short communication, and letter to the editor consistent with the aim and scope of the journal.

Original research article: original studies encompassing a conclusion based on sufficient scientific observation, investigation, and experimentation not exceeding 15 journal pages.

Case report: reporting rarely encountered clinical or laboratory cases. It can cover a maximum of 8 journal pages.

Review article: up-to-date evaluation of opinions and conducted investigations on an important topic. Only invited reviews are considered for publication in English language.

Short communication: includes new information and findings however short enough to be presented as original research. It should not exceed 6 journal pages.

Letter to the editor: illustration or short presentation of a topic bearing scientific or practical importance. It should not be more than 2 journal pages.

5. SUBMISSION CHECKLIST

  • • Title page

  • • Manuscript (Main text file)

  • • Similarity index report generated by iThenticate OR Turnitin

  • • Table(s) (All tables in a separate MS Word file)

  • • Figure(s) (Each Figure as a separate file either in TIFF or JPEG format with a resolution of at least 300 dpi and 1200 × 960 pixels)

  • • Approval letter from institutional or local animal care and use committee (optional for foreigners, however, mandatory for studies conducted in Turkey)

6. PREPARATION OF MANUSCRIPT

  • •Manuscripts submitted to the OneHealth Plus Journal are published on the understanding that they are original work and that they are neither published before nor under consideration for publication elsewhere.

  • All the manuscripts should be written in Microsoft Word with Garamond font, 11 pt., 1.5 line spacing, 2.5 cm indent, A4 page size (210 × 297 mm), single column, and justified. A continuous line number should be inserted whereas page number should be given in the middle of the header except for the first page.

  • The authors are requested to use the following sample file for the preparation of their manuscripts. The files are given below.

6.1. Title page

The title page should be submitted as a separate file indicating the article type, the title (only first letter capital), author(s) list (first letters of names and surnames should be capital), affiliation(s) of each author indicated with numbered footnotes, the corresponding author indicated by an asterisk (*) should provide the address, phone, fax, and e-mail address. All authors are required to state their ORCID numbers. The authors mention the details if the study was presented in a conference, symposium, or workshop. Declarations should be listed in the Title Page. All manuscripts must contain the following sections under the heading 'Declarations':

6.1.1. Ethics approval

Manuscripts reporting studies involving human participants, human data or human tissue must:

  • include a statement on ethics approval and consent (even where the need for approval was waived)

  • include the name of the ethics committee that approved the study and the committee’s reference number if appropriate

  • Studies involving animals must include a statement on ethics approval.

  • If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section.

6.1.2. Conflict of interest
  • All financial and non-financial competing interests must be declared in this section.

  • Please use the authors’ initials to refer to each author’s competing interests in this section.

  • If you do not have any competing interests, please state "The authors declare that they have no competing interests" in this section.

6.1.3. Consent for publication
  • If your manuscript contains any individual person’s data in any form (including individual details, images or videos), consent to publish must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent to publish.

  • You can use your institutional consent form if you prefer. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication).

  • If your manuscript does not contain data from any individual person, please state “Not applicable” in this section.

6.1.4. Author contribution

The individual contributions of authors to the manuscript should be indicated in this section with following subheading:

  • Idea, concept, and design: XXX, XXX, XXX [Initials only]

  • Data collection and analysis: XXX, XXX, XXX [Initials only]

  • Drafting of the manuscript: XXX, XXX, XXX [Initials only]

  • Critical review: XXX, XXX, XXX [Initials only]

6.1.5. Data availability
  • All manuscripts must include an ‘Availability of data and materials’ statement. Data availability statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analyzed or generated during the study. By data we mean the minimal dataset that would be necessary to interpret, replicate, and build upon the findings reported in the article. We understand that it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances data availability should still be stated in the manuscript along with any conditions for access.

6.1.6. Acknowledgements
  • Please acknowledge anyone who contributed towards the article who does not meet the criteria for authorship including anyone who provided professional writing services or materials.

  • Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.

  • If you do not have anyone to acknowledge, please write "Not applicable" in this section.

6.2. Manuscript (main text)

  • The main manuscript should include the following sections (Abstract, keywords, text, declarations, and references) without any identifying information, such as author(s) name or affiliation(s).

  • Tables should be uploaded as a single separate MS Word file. Each figure should be uploaded as a single separate MS Word file.

6.2.1. Abstract and key words
  • The abstract should not exceed 250 words and should be written in a single paragraph. In short communications, the abstract should not exceed 100 words. Abstracts in Turkish and English should contain brief information on purpose, material and method(s), results, and conclusion(s). In the abstract, abbreviations should not be used. Up to 7 keywords should be added below the abstracts.

6.2.2. Text
  • Original research articles and brief communications should be organized under 4 main headings, including introduction, materials and method, results, and discussion. The introduction should contain information directly related to the subject of the article and the purpose of the investigation should be stated. Materials and methods should be written as detailed as possible and may be divided into subparts if more than one method is used. However, there is no need to elaborate the classical and frequently used methods. If a brand is specified, the manufacturer's name and address (city, country) should be given. Findings can be presented as text, table(s), graph(s), and figure(s). The discussion should be adequate and should be written directly using the relevant sources. In the conclusion section, the results of the study and the basic recommendations should be reported without recurring findings. Abbreviations should be explained in the text, table(s), figure(s), and graph(s) at their first use. Reviews should include introduction, text, and conclusion titles. Case reports should include introduction, case(s), and discussion sections.

6.2.3. References
  • This journal uses the reference style according to the Publication Manual of the American Psychological Association (7th edition). The APA in text reference uses the (author, date) format. Your reference list should be ordered alphabetically by author and then chronologically by year of publication. Examples of frequently used references in this framework are given below. The author(s) is/are responsible for the accuracy of all references. The references should only include articles that are published or accepted. Do not include personal communications or unpublished data or materials (such as project final reports, personal websites, thesis, computer programs, poster papers, presentations, and manuscripts that are not accepted yet) as references. If the book includes a DOI, include the DOI in the reference after the publisher’s name. If a journal article has a DOI, include the DOI in the reference.

  • If possible, the manuscripts submitted to the journal should not exceed 35 references for the research article, 15 references for the short communications, and 10 references for the case reports.

6.2.3.1. Journal article
  • • One author

    • In text citation: (Tutun, 2019) or Tutun (2019) has reported that ……

    Tutun, H. (2019). Anti-Proliferative Effect of Melamine on Human Colon Adenocarcinoma Cells. Kocatepe Veteriner Dergisi, 12(3), 264-267. https://doi.org/10.30607/kvj.576695

    One author, multiple works published in the same year

    Karagoz, A., Tutun, H., Altintas, L., Alanbayi, U., Yildirim, D., & Kocak, N. (2020a). Molecular typing of drug-resistant Mycobacterium tuberculosis strains from Turkey. Journal of Global Antimicrobial Resistance, 23, 130-134. https://doi.org/10.1016/j.jgar.2020.08.012

    Karagoz, A., Tutun, H., Arslantaş, T., Altintaş, Ö., Koçak, N., & Altintaş, L. (2020b). Detection of SARS-CoV-2 using five primer sets. Ankara Üniversitesi Veteriner Fakültesi Dergisi, 68(1), 69-75. https://doi.org/10.33988/auvfd.775884

  • • Two author

    • In text citation: (Tutun and Baydan, 2009) or Tutun and Baydan (2018) have found that

    Tutun, H., & Baydan, E. (2018). Cannabinoid receptor type 2 agonist JWH-133 deteriorates the liver toxicity induced by cypermethrin. Turkish Journal of Veterinary and Animal Sciences, 42(3), 211-221. https://doi.org/10.3906/vet-1712-13

  • • Three to 20 authors

    • In text citation: (Hokugo et al., 2010) or Hokugo et al. (2010) have reported that

    Hokugo, A., Christensen, R., Chung, E. M., Sung, E. C., Felsenfeld, A. L., Sayre, J. W., Garrett, N., Adams, J. S., & Nishimura, I. (2010). Increased prevalence of bisphosphonate‐related osteonecrosis of the jaw with vitamin D deficiency in rats. Journal of bone and mineral research, 25(6), 1337-1349. https://doi.org/10.1002/jbmr.23

List all authors in the reference entry

  • • More than 20 authors

    • In text citation: (Miller et al., 2018) or Miller et al. (2018) have reported that

    Miller, T. C., Brown, M. J., Wilson, G. L., Evans, B. B., Kelly, R. S., Turner, S. T., Lewis, F., Nelson, T. P., Cox, G., Harris, H. L., Martin, P., Gonzalez, W. L., Hughes, W., Carter, D., Campbell, C., Baker, A. B., Flores, T., Gray, W. E., Green, G., . . . Lee, L. H. (2018).

    OneHealth Plus Journal

    Copyright 2023 © OneHealthPlus